1. Home
  2. PODC vs HYFT Comparison

PODC vs HYFT Comparison

Compare PODC & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PodcastOne Inc.

PODC

PodcastOne Inc.

HOLD

Current Price

$3.63

Market Cap

60.9M

Sector

N/A

ML Signal

HOLD

HYFT

MindWalk Holdings Corp.

HOLD

Current Price

$1.22

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PODC
HYFT
Founded
2013
1983
Country
United States
United States
Employees
N/A
102
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.9M
57.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
PODC
HYFT
Price
$3.63
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
130.8K
166.7K
Earning Date
06-17-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.33
N/A
Revenue Next Year
$19.04
$29.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.99
52 Week High
$3.91
$3.00

Technical Indicators

Market Signals
Indicator
PODC
HYFT
Relative Strength Index (RSI) 65.21 50.73
Support Level $2.13 $1.16
Resistance Level N/A $1.31
Average True Range (ATR) 0.38 0.09
MACD 0.08 0.00
Stochastic Oscillator 77.46 40.18

Price Performance

Historical Comparison
PODC
HYFT

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: